Clinical Research - Single Molecule, Real-time (smrt) Sequencing Market Statistics
The global clinical research single molecule, real-time (smrt) sequencing market size was valued at US$ 20,543.5 million in 2020 and is estimated to grow at a compound annual growth rate (CAGR) of 16.8% from 2020 to 2030.
Related Statistics
Clinical research - Single molecule, real-time (smrt) sequencing market highlights
- The global clinical research segment generated a revenue of USD 20,543.5 million in 2020 and is expected to reach USD 97,053.8 million by 2030.
- The market is expected to grow at a CAGR (2021 - 2030) of 17% by 2030.
- In terms of region, North America was the largest revenue generating market in 2020.
- Country-wise, India is expected to register the highest CAGR from 2021 to 2030.
Market summary
| Market revenue in 2020 | USD 20,543.5 million |
| Market revenue in 2030 | USD 97,053.8 million |
| Growth rate | 17% (CAGR from 2021 to 2030) |
| Historical data covered | 2018 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2030 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Single Molecule, Real-Time (SMRT) Sequencing Market Scope
Single molecule, real-time (smrt) sequencing market segmentation & scope
Single Molecule, Real-Time (SMRT) Sequencing Market Outlook
- HTML
- PPT
- -
Everything on Single Molecule, Real-Time (SMRT) Sequencing Market in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
